Itama Ranoraya PT
Itama Ranoraya PT operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.
Business. Itama Ranoraya PT (IRRA.JK) is a healthcare company engaged in the medical equipment, supplies, and distribution industry. The firm operates within the Healthcare Services & Equipment sector, focusing on product sales. It is headquartered in Indonesia and is primarily listed on the Indonesia Stock Exchange (IDX). Specific details regarding operating segments and geographic revenue mix are not disclosed.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Itama Ranoraya PT (IRRA.JK) is a healthcare company engaged in the medical equipment, supplies, and distribution industry. The firm operates within the Healthcare Services & Equipment sector, focusing on product sales. It is headquartered in Indonesia and is primarily listed on the Indonesia Stock Exchange (IDX). Specific details regarding operating segments and geographic revenue mix are not disclosed.
Itama Ranoraya PT has a debt-to-equity ratio of 0.47, indicating a relatively conservative capital structure with a moderate level of leverage. The company's liquidity is assessed as medium, and its current ratio of 1.28 suggests it has sufficient short-term assets to cover its short-term liabilities, though not with a large buffer.
The company's profitability is modest, with a return on equity of 0.97% and a return on assets of 0.38%. These figures are below the typical thresholds for strong performance in the healthcare services and equipment industry, suggesting that the company is not generating significant returns relative to its equity and asset base.
Itama Ranoraya PT's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no detailed geographic breakdown provided. This lack of diversification could expose the company to higher risks if demand in its primary market fluctuates.
The company's growth trajectory is not clearly defined in the available data, as there are no specific numeric deltas provided for the current or next fiscal year. However, the company's operating cash flow is negative, which may indicate challenges in generating sufficient cash from operations to support growth initiatives.
The risk assessment for Itama Ranoraya PT highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could impact its ability to meet short-term obligations without additional financing.
There are no recent events or filings mentioned in the provided data that would significantly impact the company's operations or financial position. The absence of recent transcripts or filings suggests a lack of public disclosures that could provide further insight into the company's strategic direction or operational performance.
- Itama Ranoraya PT has a conservative capital structure with a debt-to-equity ratio of 0.47.
- The company's return on equity and return on assets are below typical industry benchmarks.
- The company's revenue is concentrated in a single business segment, with no geographic diversification disclosed.
- The company's liquidity is assessed as medium, with a current ratio of 1.28.
- The company's operating cash flow is negative, which may impact its ability to fund operations and growth.
Bull / Bear case
Generated · model-assistedDebt-to-equity ratio of 0.47 is well below the 0.20 cohort median, suggesting a conservative leverage profile.
Revenue grew 12.6% year-over-year to IDR 1.1 trillion, showing recent top-line expansion momentum.
Net income increased 23.0% year-over-year, outpacing revenue growth and highlighting operational leverage.
Cash conversion of -13.3% falls in the bottom quartile, signaling poor ability to turn earnings into cash.
Return on equity of 0.97% lags the 1.42% cohort median, indicating inefficient use of shareholder capital.
High credit risk flag suggests significant potential for loan losses or counterparty defaults impacting financial stability.
Four-year revenue CAGR of -4.4% reveals a long-term declining trend despite recent annual growth.
In focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Itama Ranoraya PT Market data — financials · 2026-05-28